Novartis
NOVN
Real-time BATS EUROPE - 06/20 05:30:00 pm
73.96CHF
+1.06%
Prev.73.2800
Open73.5000
High74.5200
Low73.4400
Volume6 344 531
Financials
Sales 2018 52 590 M
EBIT 2018 13 229 M
R. net 2018 10 415 M
Debt 2018 13 548 M
Rend. 2018 4,03%
P/E ratio 2018 15,27
P/E ratio 2019 18,11
EV / Sales 2018 3,85x
EV / Sales 2019 3,70x
Capitalization 189 B
Company
Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products.It operates through the following segments: Innovative Medicines, Alcon, Sandoz, and Corporate.The Innovative Medicines segment researches, develops, manufactures, distributes and...
Sector :
Pharmaceuticals - NEC
Calendar :
2018-07-18 Earnings Release
Trading Rating :
Investor Rating :
Latest news
09:58pGLOBAL CARCINOID SYNDROME MANAGEMENT MARKET GROWTH ANALYSIS, SHARE, DEMAND BY REGIONS, TYPES AND ANALYSIS OF KEY PLAYERS- RESEARCH FORECASTS TO 2023 : The research provide Industry Overview, Market history, Market competition, Development and Trades and Trade policies. The research provide investment analysis opportunities market shares profiling top key players Novartis International AG (Sandoz), Pharmascience Inc., Omega Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Mylan NV, Ipsen
AQ
01:41pNOVARTIS : survey uncovers real-world impact of immune thrombocytopenia or ITP, a rare blood disease, on patients' quality of life
AQ
01:41pNOVARTIS : study of real-world data concludes Jakavi is associated with a reduction in risk of death and dangerous blood clots for patients with rare blood cancer
AQ
01:41pNOVARTIS : Sandoz presents new long-term and switching data for biosimilars Zessly and Erelzi in rheumatoid arthritis
AQ
06/19Payers, drugmakers face off over CAR T Medicare coverage
AQ
06/18NOVARTIS : JULIET Trial of Kymriah Demonstrates More Than One-Year Durability of Responses in Adults With Relapsed or Refractory DLBCL
AQ
06/18NOVARTIS INTERNATIONAL AG : Alcon AcrySof IQ PanOptix Trifocal Intraocular Lens Shows Superior Visual Performance in Head-to-Head Trial Post-Cataract Surgery
AQ
06/18NOVARTIS INTERNATIONAL AG : Alcon AcrySof® IQ PanOptix® trifocal intraocular lens shows superior visual performance in head-to-head trial post-cataract surgery
GL
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralBearishBearish
Resistance79,079,079,8
Spread/Res.-6,4%-6,4%-7,2%
Spread/Supp.1,5%1,5%7,7%
Support73,073,068,8